-
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
Eleveld, T. F., Vernooij, L., Schild, L., Koopmans, B., Alles, L. K., Ebus, M. E., Dandis, R., van Tinteren, H., Caron, H. N., Koster, J., van Noesel, M. M., Tytgat, G. A. M., Eising, S., Versteeg, R., Dolman, M. E. M. & Molenaar, J. J., 2023, In: Frontiers in Oncology. 13, 1130034.Research output: Contribution to journal › Article › Academic › peer-review
-
High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells
Vernooij, L., Bate-Eya, L. T., Alles, L. K., Lee, J. Y., Koopmans, B., Jonus, H. C., Schubert, N. A., Schild, L., Lelieveld, D., Egan, D. A., Kerstjens, M., Stam, R. W., Koster, J., Goldsmith, K. C., Molenaar, J. J. & Dolman, M. M. E., 1 Jun 2021, In: Molecular Cancer Therapeutics. 20, 6, p. 1161-1172 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses
Schubert, N. A., Schild, L., van Oirschot, S., Keller, K. M., Alles, L. K., Vernooij, L., Nulle, M. E., Dolman, M. E. M., van den Boogaard, M. L. & Molenaar, J. J., Jan 2021, In: European Journal of Cancer. 142, p. 1-9 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications